Trident Lifeline Reports Strong Growth and Low Debt Amid Market Evaluation Adjustments

Feb 12 2025 06:57 PM IST
share
Share Via
Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation amid strong financial performance for Q3 FY24-25. The company reported a 43.10% increase in net sales and a 57.52% rise in operating profit, maintaining a low debt-to-equity ratio and consistent growth over three quarters.
Trident Lifeline, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment reflecting its current market dynamics. The company has reported positive financial performance for the third quarter of FY24-25, showcasing a robust annual growth rate in net sales of 43.10% and an impressive operating profit increase of 57.52%.

In terms of financial health, Trident Lifeline maintains a low debt-to-equity ratio of 0.24, indicating a conservative approach to leverage. The company has consistently delivered positive results over the last three consecutive quarters, with net sales for the first nine months reaching Rs 46.91 crore, marking a growth of 82.81%. Additionally, the profit after tax for the same period has surged to Rs 9.43 crore, reflecting a significant increase of 123.46%.

The stock's technical indicators suggest a mildly bullish trend, with the Bollinger Band showing bullish signals since early February 2025. Despite a recent return of 32.98% over the past year, Trident Lifeline's valuation metrics indicate it is trading at a discount compared to its historical averages, with a PEG ratio of 0.3.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News